SCHEMBL2160327

SCHEMBL2160327

Nc1ccn(-c2ccccn2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPO P05164 1/20 0.46
TPO P07202 1/20 0.46
CYP3A4 P08684 1/20 0.46
GRM5 P41594 1/20 0.46
NOS3 P29474 1/20 0.45
NOS1 P29475 1/20 0.45
NOS2 P35228 1/20 0.45
PI4KA P42356 1/20 0.45
PI4K2B Q8TCG2 1/20 0.45
PI4K2A Q9BTU6 1/20 0.45
PI4KB Q9UBF8 1/20 0.45
MTOR P42345 2/20 0.43
RPTOR Q8N122 1/20 0.41
MLST8 Q9BVC4 1/20 0.41
CHEK1 O14757 1/20 0.40
AURKA O14965 1/20 0.40
DAPK3 O43293 1/20 0.40
JAK2 O60674 1/20 0.40
PRKD3 O94806 1/20 0.40
MAP4K4 O95819 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29563483 1.00 MPO (0.46) MPOTPOCYP3A4GRM5NOS3
SCHEMBL19119928 0.81 GRM5 (0.46) MPOTPOCYP3A4GRM5MTOR
SCHEMBL15638519 0.78 NOS3 (0.39) NOS3NOS1NOS2PI4KAPI4K2B
SCHEMBL28076029 0.77 GRM5 (0.46) MPOTPOCYP3A4GRM5MTOR
SCHEMBL2643353 0.77 GRM5 (0.46) MPOTPOCYP3A4GRM5MTOR
SCHEMBL3156955 0.77 GRM5 (0.46) MPOTPOCYP3A4GRM5MTOR
SCHEMBL38651177 0.77 MAPT (0.63) GRM5MTORRPTORMLST8MAPT
SCHEMBL8086526 0.77 GRM5 (0.46) MPOTPOCYP3A4GRM5MTOR
SCHEMBL1907360 0.77 MAPT (0.63) GRM5MTORRPTORMLST8MAPT
SCHEMBL20242047 0.76 HSP90AA1 (0.43) MPOMAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2526098-B1 NITROGEN-CONTAINING HETEROARYL DERIVATIVES HOFFMANN LA ROCHE (CH) 2018-07-11 EP claimed
US-8470820-B2 Nitrogen-containing heteroaryl derivatives HOFFMAN-LA ROCHE INC. (US) 2013-06-25 US claimed
US-11548854-B2 Heterocyclic compounds as pesticides BAYER CROPSCIENCE AG (DE) 2023-01-10 US disclosed
US-11332448-B2 Heterocyclic compounds as pesticides BAYER CROPSCIENCE AG (DE) 2022-05-17 US disclosed
CN-113243374-B Heterocyclic compounds as pesticides 拜耳农作物科学股份公司 2022-04-26 CN disclosed
CN-113243374-A Heterocyclic compounds as pesticides 拜耳农作物科学股份公司 2021-08-13 CN disclosed
CN-108477173-B Heterocyclic compounds as pesticides 拜耳农作物科学股份公司 2021-07-02 CN disclosed
CN-109476643-B Pyrazolylaminobenzimidazole derivatives as JAK inhibitors 伊莱利利公司 2021-06-08 CN disclosed
EP-3484875-B1 PYRAZOLYLAMINOBENZIMIDAZOLE DERIVATIVES AS JAK INHIBITORS LILLY CO ELI (US) 2021-04-07 EP disclosed
US-10961201-B2 Heterocyclic compounds as pesticides BAYER CROPSCIENCE AG (DE) 2021-03-30 US disclosed
US-20210053924-A1 HETEROCYCLIC COMPOUNDS AS PESTICIDES BAYER CROPSCIENCE AG (DE) 2021-02-25 US disclosed
CN-1934100-A Substituted quinazoline or pyridopyrimidine derivatives BANYU PHARMA CO LTD (JP) 2007-03-21 CN disclosed
EP-1734040-A1 SUBSTITUTED QUINAZOLINE OR PYRIDOPYRIMIDINE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2006-12-20 EP disclosed
CN-1708483-A Process for preparing pyrazole compounds BANYU PHARMA CO LTD (JP) 2005-12-14 CN disclosed
US-4881965-A CONTROLLING WILD OATS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1989-11-21 US disclosed
EP-0318602-A1 Pyrazolesulfonamide derivative, process for its production and herbicide containing it NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1989-06-07 EP disclosed
EP-0207285-A1 5-Amino-1-pyridyl-pyrazoles BAYER AG (DE) 1987-01-07 EP disclosed
CN-86100911-A The preparation method of pyrazoles sulfone amide derivative and the weedicide that contains this kind derivative 1986-09-24 CN disclosed
US-4490376-A ANTIULCER AND SECRETORY AGENTS FARMITALIA CARLO ERBA S.P.A (IT) 1984-12-25 US disclosed
US-4482555-A ANTIINFLAMMATORY, ANTIARTHRITIC AGENTS, AND ANALGESIC FARMITALIA CARLO ERBA S.P.A. (IT) 1984-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10961201-B2 Heterocyclic compounds as pesticides DDT, ACHE, PTMS MPO 1163/4885TPO 3273/4885CYP3A4 131/4885
US-11548854-B2 Heterocyclic compounds as pesticides DDT, ACHE, PTMS MPO 1163/4885TPO 3273/4885CYP3A4 131/4885
US-20210053924-A1 HETEROCYCLIC COMPOUNDS AS PESTICIDES DDT, ACHE, PTMS MPO 1163/4885TPO 3273/4885CYP3A4 131/4885
US-11332448-B2 Heterocyclic compounds as pesticides DDT, ACHE, PTMS MPO 1163/4885TPO 3273/4885CYP3A4 131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.